Capricorn Venture Partners announces first close of its Capricorn Health-tech Fund

Leuven, Belgium: 5 January 2011 - Capricorn Venture Partners announced today that its Capricorn Health-tech Fund raised € 42 million in a first closing which took place on December 22, 2010.

End 2009 Capricorn Venture Partners launched the Capricorn Health-tech Fund (CHF) focusing on early to mid stage human health-technology companies in Europe. Capricorn Venture Partners defines health-technology as any technology based product used for the prevention, the diagnosis or the treatment of diseases and medical indications in humans. This includes the following subsectors: biopharmaceutical and pharmaceutical drugs, vaccines, medical devices, medical imaging, diagnostics, (research) equipment, nutraceuticals and functional foods.

In addition to a number of private investors and two universities the investors in this first close include Dexia Insurance Belgium, FPIM (Federale Participatie- en Investeringsmaatschappij), PMV (Participatie-Maatschappij Vlaanderen), SRIW (Société Régionale d'Investissement de Wallonie) and Quest for Growth.

More info on the press release.


Next > Green Biologics selected as new energy pioneer

Previous > Leuven based Venture Capital and Private Equity providers plan joining forces